Release kinetics of VEGF165 from a collagen matrix and structural matrix changes in a circulation model

Head and Face Medicine

Volumn 6, Issue 1, 2010, Pages

  Kleinheinz, Johannes ^a   Jung, Susanne ^a   Wermker, Kai ^a   Fischer, Carsten ^b   Joos, Ulrich ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Private practice   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYTOKINE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANIMAL; ANIMAL MODEL; ARTICLE; BONE REGENERATION; HORSE; HUMAN; IN VITRO STUDY; METABOLISM; PHYSIOLOGY;

ANIMALS; BONE REGENERATION; COLLAGEN; CYTOKINES; HORSES; HUMANS; MODELS, ANIMAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77954667182     PISSN: None     EISSN: 1746160X     Source Type: Journal    
DOI: 10.1186/1746-160X-6-17     Document Type: Article

References (27)

1. Reddi A. Bone and cartilage differentiation. Curr Opin Gen Develop 1994, 4:737-744.
2. Caplan AI. Cartilage begets bone versus endochondral myeloporests. Clin Orthop 1990, 261:257-267.
3. Kübler N. Osteoinduktion und -reparation. Mund Kiefer GesichtsChir 1997, 1:2-25. 10.1007/BF03043502, 9483923.
4. Schmidt K, Swoboda H. Die Bedeutung matrixgebundener Zytokine für die Osteoinduktion und Osteogenese. Implantologie 1995, 2:127-148.
5. Sauter E, Nesbit M, Watson J, Klein-Szanto A, Litwin S, Herlyn M. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res 1999, 5:775-782.
6. Schliephake H, Jamil M, Knebel J. Experimental reconstruction of the mandible using polylactic acid tubes and basic fibroblast growth factor in alloplastic scaffolds. J Oral Maxillofac Surg 1998, 56:616-626. 10.1016/S0278-2391(98)90463-3, 9590344.
7. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea K, Powell-Braxton L, Hillan K, Moore M. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380:439-443. 10.1038/380439a0, 8602242.
8. Kleinheinz J, Joos U. Serum concentration of VEGF and bFGF in patients with sagittal split ramus osteotomy. Int J Oral Maxillofac Surg 1999, 28:539.
9. Hollinger J, Wong M. The integrated process of hard tissue regeneration with special emphasis on fracture healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996, 82:594-606. 10.1016/S1079-2104(96)80431-8, 8974129.
10. Mattei MG, Borg JP, Rosnet O, Marmé D, Birnbaum D. Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) genes to human chromosome 6p12-p21 and 14q24-q31 regions, respectively. Genomics 1996, 32:168-9. 10.1006/geno.1996.0098, 8786112.
11. Drake CJ, Little CD. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc Natl Acad Sci USA 1995, 92:7657-61. 10.1073/pnas.92.17.7657, 41204, 7543999.
12. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989, 246:1309-12. 10.1126/science.2479987, 2479987.
13. Plate KH, Breier G, Risau W. Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 1994, 4:207-18. 10.1111/j.1750-3639.1994.tb00835.x, 7524960.
14. Senger DR, Van de Water L, Brown LF, Nagy JA, Yeo KT, Yeo TK, Berse B, Jackman RW, Dvorak AM, Dvorak HF. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 1993, 12:303-24. 10.1007/BF00665960, 8281615.
15. Hutmacher D, Kirsch A, Ackermann K, Hürzeler M. Matrix and carrier for bone growth factors: state of the art and future perspectives. 1998, Berlin Heidelberg, Springer.
16. Wang D, Yamazaki K, Nohtomi K, Shizume K, Ohsumi K, Shibuya M, Sato K. Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cells. J Bone Miner Res 1996, 11:472-479. 10.1002/jbmr.5650110408, 8992878.
17. Ramselaar M, Driessens F, Kalk W, De Wijn J, Van Mullem P. Biodegradation of four calcium phosphate ceramics; in vivo rates and tissue interactions. J Mat Sci 1991, 2:63-70.
18. Hemprich A, Lehmann R, Khoury F, Schulte A, Hidding J. Filling cysts with type 1 bone collagen. Dtsch Zahnarztl Z 1989, 44:590-592.
19. Basle M, Lesourd M, Grizon F, Pascaretti C, Chappard D. Typ-I-Kollagen im xenogenen Knochenmaterial reguliert Anbindung und Verbreitung von Osteoblasten über die β1-Integrin-Untereinheit. Orthopäde 1998, 27:136-142.
20. Burchardt H. Biology of bone transplantation. Orthop Clin North Am 1987, 18:187-196.
21. Crotts G, Park T. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. J Microencapsulation 1998, 15:699-713. 10.3109/02652049809008253, 9818948.
22. Arnold F, West D. Angiogenesis in wound healing. Pharm Ther 1991, 52:407-422.
23. Iruela-Arispe M, Dvorak H. Angiogenesis: a dynamic balance of stimulators and inhibitors. Thrombosis and Haemostasis 1997, 78:672-677.
24. Kremer C, Breier G, Risau W, Plate KH. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system. Cancer Res 1997, 57:3852-9.
25. Safi J, DiPaula A, Riccioni T, Kajstura J, Ambrosio G, Becker L, Anversa P, Capogrossi M. Adenovirus-mediated acidic fibroblast growth factor gene transfer induces angiogenesis in the nonischemic rabbit heart. Microvasc res 1999, 58:238-249. 10.1006/mvre.1999.2165, 10527767.
26. Franceschi RT. Biological approaches to bone regeneration by gene therapy. J Dent Res 2005, 84:1093-103. 10.1177/154405910508401204, 16304438.
27. Isner J, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Wash K, Symes J. Clinical evidence of angiogenesis after gene transfer of phVEGF165 in patient with ischemic limb. Lancet 1996, 348:370-374. 10.1016/S0140-6736(96)03361-2, 8709735.